Cytokinetics’ (CYTK) CEO Robert Blum on Q2 2017 Results – Earnings Call Transcript

… ‘s North American pharmaceuticals business and previously he served as … as international expansion, as our business may mature and we execute … in the U.S. and Canada.
Additionally, Astellas recently began a …